Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases
- PMID: 21833518
- DOI: 10.1007/s00296-011-2053-1
Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases
Abstract
To describe and compare the diagnosis, demographics and management of systemic lupus erythematosus (SLE) related versus idiopathic acute transverse myelitis during the initial presentation of the disease. We undertook a chart review of the hospital records of patients admitted to our hospital from 1994 until 2007 and had the diagnosis of SLE related and idiopathic acute transverse myelitis. Demographics, laboratory and imaging studies, diagnosis and treatment were recorded in both groups and analyzed in a case control fashion. We identified 15 patients with SLE-related acute transverse myelitis (SLE-ATM) and 39 idiopathic (I-ATM) cases between 1994 and 2007. Patients with SLE were more likely to be African American, have CNS demyelinating lesions on MRI, a high IgG% on their CSF analysis and a higher sedimentation rate on presentation. Treatment with high-dose steroids was instituted in both groups of patients, though SLE patients had a longer hospital stay by an average of 5 days. SLE-ATM patients were more likely to be African American as compared to I-ATM patients, have CNS demyelinating lesions on MRI, a high IgG% on CSF analysis and a higher sedimentation rate on presentation. The hospital stay for SLE patients was 5 days longer than the idiopathic patients. This study underlines the importance of early diagnosis of patients who develop ATM related to SLE.
Similar articles
-
Clinical features and prognoses of acute transverse myelitis in patients with systemic lupus erythematosus.Korean J Intern Med. 2019 Mar;34(2):442-451. doi: 10.3904/kjim.2016.383. Epub 2018 Jan 5. Korean J Intern Med. 2019. PMID: 29294596 Free PMC article.
-
Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome.J Rheumatol. 1998 Mar;25(3):467-73. J Rheumatol. 1998. PMID: 9517765
-
Transverse Myelitis in Systemic Lupus Erythematosus: Clinical Features and Prognostic Factors in a Large Cohort of Latin American Patients.J Clin Rheumatol. 2021 Sep 1;27(6S):S204-S211. doi: 10.1097/RHU.0000000000001322. J Clin Rheumatol. 2021. PMID: 32028309
-
Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature.J Rheumatol. 1990 Jan;17(1):89-92. J Rheumatol. 1990. PMID: 2179553 Review.
-
Acute transverse myelitis in systemic lupus erythematosus: a case of rapid diagnosis and complete recovery.Conn Med. 1998 Jul;62(7):387-90. Conn Med. 1998. PMID: 9707792 Review.
Cited by
-
Myelitis in systemic lupus erythematosus: clinical features, immunological profile and magnetic resonance imaging of five cases.Spinal Cord Ser Cases. 2016 Jul 7;2:16005. doi: 10.1038/scsandc.2016.5. eCollection 2016. Spinal Cord Ser Cases. 2016. PMID: 28053749 Free PMC article.
-
Transverse myelitis.Neurol Clin. 2013 Feb;31(1):79-138. doi: 10.1016/j.ncl.2012.09.008. Neurol Clin. 2013. PMID: 23186897 Free PMC article. Review.
-
Persistent "MRI-negative" lupus myelitis-disease presentation, immunological profile and outcome.Front Neurol. 2022 Oct 31;13:968322. doi: 10.3389/fneur.2022.968322. eCollection 2022. Front Neurol. 2022. PMID: 36388234 Free PMC article.
-
Conventional and advanced imaging in neuromyelitis optica.AJNR Am J Neuroradiol. 2014 Aug;35(8):1458-66. doi: 10.3174/ajnr.A3592. Epub 2013 Jun 13. AJNR Am J Neuroradiol. 2014. PMID: 23764723 Free PMC article. Review.
-
Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica.Nat Rev Neurol. 2011 Nov 1;7(12):688-98. doi: 10.1038/nrneurol.2011.176. Nat Rev Neurol. 2011. PMID: 22045269 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous